NUVECTIS PHARMA, INC.
Profile
Company Names
NUVECTIS PHARMA, INC.
Addresses
1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ 07024
Phone Numbers
(201) 614-3151
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
2020
State Incorporated:
DELAWARE
Total Amount Raised:
$31,178,636.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-07-27
$15,878,637.00
$15,878,637.00
$0.00
Equity
1
2021-05-23
$15,299,999.00
$15,299,999.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
RON
BENTSUR
EXECUTIVE OFFICER, DIRECTOR
MATTHEW
KAPLAN
DIRECTOR
WESTCORE PROPERTIES, LLC
| ARS V WESTCORE REIT
| ALMANAC REALTY SECURITIES VII, L.P.
| ARS VII (SIDECAR I), L.P.
| ARS VII (SIDECAR II), L.P.
| ARS VII (SIDECAR III), L.P.
| ARS VII (SIDECAR IV), L.P.
| ARS VI WINTER REIT, LLC
| ALMANAC MOUNT AUBURN REIT, LLC
| CMTG INVESTOR, L.P.
| ARS VII WESTCORE REIT
| ARS VII PREP REIT
| ARS VII MERRITT REIT
| ALMANAC REALTY SECURITIES VIII, L.P.
| ARS VIII (SC I), L.P.
| ARS VIII (SC V), L.P.
| ARS VIII (SC II), L.P.
| CENTRY PHARMA, INC.
| NUVECTIS PHARMA, INC.
| ALMANAC REALTY SECURITIES IX, L.P.
| NB ALMANAC REALTY SECURITIES IX (PARALLEL), L.P.
| ARS IX (SC II), L.P.
| SCRIBL, INC.
| ALMANAC REALTY SECURITIES X, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-07-27
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-05-23
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-05-23
